HeartSciences (HSCSW) Amortization of Deferred Charges (2022 - 2026)

HeartSciences (HSCSW) has reported Amortization of Deferred Charges for 4 consecutive years, with $100833.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Amortization of Deferred Charges fell 8.29% year-over-year to $100833.0; the trailing twelve-month figure through Apr 2026 stood at $584613.0 (up 142.96% YoY), and the FY2026 full-year result was $495950.0, up 73.49% from the prior year.
• Amortization of Deferred Charges slipped to $100833.0 in Q2 2026 per HSCSW's latest filing, from $263880.0 in the prior quarter.
• Across five years, Amortization of Deferred Charges topped out at $263880.0 in Q4 2025 and bottomed at $20719.0 in Q1 2024.
• Historically, Amortization of Deferred Charges has averaged $112428.5 across 4 years, with a median of $109950.0 in 2025.
• The sharpest annual moves came in 2025 and 2026: Amortization of Deferred Charges soared 430.67% in 2025, then dropped 8.29% in 2026.
• Over 4 years, Amortization of Deferred Charges stood at $61381.0 in 2022, then plunged by 66.25% to $20719.0 in 2024, then soared by 1173.61% to $263880.0 in 2025, then sank by 61.79% to $100833.0 in 2026.
• According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $100833.0, $263880.0, and $109950.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.